Philip F Hughes

Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.

Timothy A J Haystead, Asim K Bera, Philip F. Hughes, 2017, Cell chemical biology.

Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90.

Briana Foley, Laura G. Dubois, Philip F. Hughes, 2010, Chemistry & biology.

Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.

M. G. Johnson, M. P. Lynch, Philip F. Hughes, 2002, Journal of medicinal chemistry.